Expression vector of human Fra2 (FOSL2).
Alternative name | SET-0038_10 |
---|---|
Clone info. | Expression vector of human Fra2 (FOSL2). Expression was confirmed by Western blotting with anti-FLAG antibody. |
Comment | PCR template:HeLa cells cDNA. dT,Random primer mix. PCR cloning, forward primer: atgtaccaggattatcccgg; reverse primer: ttacagagccagcagagtgg. |
Vector backbone | pCMV_S-FLAG (RDB05956) (Plasmid) |
Size of vector backbone | 5.5 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Gene/insert name | Human Fra2; FOSL2 cDNA |
Depositor|Developer | DNA Bank, | |
Sequence | RDB06065z.seq | Remarks, protocol and/or map (pdf) | RDB06065.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL in any publication. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 発表に際し、理研BRCから入手したことを明記すること。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB06065 | pCMFlag_hsFOSL2 | DNA solution |
Materials & Methods section:
The pCMFlag_hsFOSL2 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06065). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB18653_B1Aip1-1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV_Forward Sequence file: RDB18653_B1Aia.seq |
---|
>06065_18653_B1Ai_CMV_Forward_D02_11_ABI24.ab1 1 NNNNNNNNNN NNCNNTTGNN GCNNTGGGCG GTAGGCGTGT ACGGTGGGAG GTCTATATAA 61 GCAGAGCTCT CTGGCTAACT AGAGAACCCA CTGCTTACTG GCTTATCGAA ATTAATACGA 121 CTCACTATAG GGAGACCCAA GCTGAATTCA CCATGGACTA CAAGGACGAT GACGATAAGG 181 CGGCCATGTA CCAGGATTAT CCCGGGAACT TTGACACCTC GTCCCGGGGC AGCAGCGGCT 241 CTCCTGCGCA CGCCGAGTCC TACTCCAGCG GCGGCGGCGG CCAGCAGAAA TTCCGGGTAG 301 ATATGCCTGG CTCAGGCAGT GCATTCATCC CCACCATCAA CGCCATCACG ACCAGCCAGG 361 ACCTGCAGTG GATGGTGCAG CCCACAGTGA TCACCTCCAT GTCCAACCCA TACCCTCGCT 421 CGCACCCCTA CAGCCCCCTG CCGGGCCTGG CCTCTGTCCC TGGACACATG GCCCTCCCAA 481 GACCTGGCGT GATCAAGACC ATTGGCACCA CCGTGGGCCG CAGGAGGAGA GATGAGCAGC 541 TGTCTCCTGA AGAGGAGGAG AAGCGTCGCA TCCGGCGGGA GAGGAACAAG CTGGCTGCAG 601 CCNAGTGCCG GANCCGACGC CNGGANCTGA NAGANAANCT GCNNGCGGAN ACAGANGANC 661 TGGANGANGA NAANTCNNNC TGCNNANNNN ANTGNTGANC TGCNNNNNNN NANNNANANN 721 CTNNNNNNNN NN // |
Primer: bGH_rev3 Sequence file: RDB18653_B1Aib.seq |
>06065_18653_B1Ai_bGH_rev3_E02_14_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN GNNGGNNNNN NNCAGATGGC TGGCAACTAG AAGGCACAGT 61 CGAGGCTGAT CAGCGAGCTC TAGCATTTAG GTGACACTAT AGAATAGGGC CCTCTAGATG 121 CATGCTCGAG CGGCCTTACA GAGCCAGCAG AGTGGGGGAG TTCAAGGAGT CTGATGATTG 181 GTCCCCGCTG CTACTGCTTC TGCGGTGAGC CTTGGAGCAG GATTCGGAGG GAGATGCGGG 241 TGACTCCTGC TCCAGGACGC TAGGATAGGT GAAGACGAGG TTCGAGGTGC CCGGAGTGAC 301 AGCAGGTGTG GAGGTCACCA CGATGGGGGT GTGCAGGGGC TCCTCACCGT AGAAGCCCCC 361 AGCAATGCTG ATGGGCTTGA TGACAGAGCG CTGGGCCTTG TCCAGCCCCG CCGACGAGGA 421 CGAGGGGCTG TCCTCTTCCA GGGGCTCCTG TTTCACCACT ACAGCGCCCA CCGAGCCACC 481 CCCACTGCGC ATGGGCTGCA GCCCAGGGGC TGGGGGCGAT CGGCGCTCCT CGGGGCTAAT 541 CTTGCACACT GGGCCGTGAG CCACCAACAT GAACTCCAGC TTCTCCTTCT CCTTCTGCAG 601 CTCANCAATC TCCTTCTGCA NGCCTGACTT CTCCTCCTCC AGCTCCTCTG TCTCCNCCTG 661 CAGCTTCTCT GTCAGCTCCC GGCGTCNGNT CCGGNACTTG GNNGCNNCNN GCTNGNNCNN 721 NNNCNNNNNN NNNN // |
Primer: SV40pro_ori_F Sequence file: RDB18653_B1Aic.seq |
>06065_18653_B1Ai_SV40pro_ori_F_F02_17_ABI24.ab1 1 NNNNNNNNNN NNNNNNNCGC CTCNGCCTCT GNNCTATTCC NGAAGTAGTG AGGAGGCTTT 61 TTTGGAGGCC TAGGCTTTTG CAAAAAGCTC CCGGGAGCTT GGATATCCAT TTTCGGATCT 121 GATCAAGAGA CAGGATGAGG ATCGTTTCGC ATGATTGAAC AAGATGGATT GCACGCAGGT 181 TCTCCGGCCG CTTGGGTGGA GAGGCTATTC GGCTATGACT GGGCACAACA GACAATCGGC 241 TGCTCTGATG CCGCCGTGTT CCGGCTGTCA GCGCAGGGGC GCCCGGTTCT TTTTGTCAAG 301 ACCGACCTGT CCGGTGCCCT GAATGAACTG CAGGACGAGG CAGCGCGGCT ATCGTGGCTG 361 GCCACGACGG GCGTTCCTTG CGCAGCTGTG CTCGACGTTG TCACTGAAGC GGGAAGGGAC 421 TGGCTGCTAT TGGGCGAAGT GCCGGGGCAG GATCTCCTGT CATCTCACCT TGCTCCTGCC 481 GAGAAAGTAT CCATCATGGC TGATGCAATG CGGCGGCTGC ATACGCTTGA TCCGGCTACC 541 TGCCCATTCG ACCACCAAGC GAAACATCGC ATCGAGCGAG CACGTACTCG GANGGAAGCC 601 GGTCTTGTCN ATCAGGANGA NCTGGACNAA GAGCNTCANG GGCTCGCGNC NGCCNAACTG 661 NTCNCCAGGC TCANNNNGCG CATGNCCNAN GGCNANGNNC TCNNCNNGNN CNNNNGNNNN 721 NGNCNGNTNN NNNNNNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content